Effect of uric-acid-lowering therapy on progression of chronic kidney disease: A meta-analysis

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 4, 2014, Pages 476-481

  Zhang, Ye Fang ^a   He, Fan ^a   Ding, Hong Hui ^a   Dai, Wei ^a   Zhang, Qian ^a   Luan, Hong ^a   Lv, Yong Man ^a   Zeng, Hong Bing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

chronic kidney disease; hyperuricemia; meta analysis; uric acid lowering

Indexed keywords

CREATININE; UREA; URIC ACID;

BLOOD; BLOOD PRESSURE; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; MALE; MEDLINE; META ANALYSIS; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

BLOOD PRESSURE; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; MALE; PUBMED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UREA; URIC ACID;

EID: 84906280472     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1302-4     Document Type: Article

References (31)

1. Schlesinger N, Moore DF, Sun JD, et al. A survey of current evaluation and treatment of gout. J Rheumatol, 2006,33(10):2050-2052
2. Nakaya I, Namikoshi T, Tsuruta Y, et al. Management of asymptomatic hyperuricemia in patients with chronic kidney disease by Japanese nephrologists: A questionnaire survey. Nephrology (Carlton), 2011,16(5):518-521
3. Sonoda H, Takase H, Dohi Y, et al. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol, 2011,33(4):352-357
4. Ben-Dov IZ, Kark JD. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant, 2011,26(8):2558-2566
5. Chang HY, Tung CW, Lee PH, et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population. Am J Med Sci, 2010, 339(6):509-515
6. Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis, 2010,56(2):264-272
7. Satirapoj B, Supasyndh O, Chaiprasert A, et al. Relationship between serum uric acid levels with chronic kidney disease in a Southeast Asian population. Nephrology (Carlton), 2010,15(2):253-258
8. Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol, 2000,10(6):403-409
9. Higgins J, Altman DG. Assessing risk of bias in included studies. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Oxford: Cochrane Collaboration, 2008.
10. Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis, 2006,47(1):51-59
11. Liu J, Sheng D. Allopurinol in lowering serum uric acid level for the delay of the progression of chronic renal disease. China Pharmac, 2007,18(32):2524-2525
12. Zhou DY, Zhao YJ, Xiao X, et al. Treatment of hyperuricemia in chronic kidney disease patients and its effect. Mod Med J China (Chinese), 2009,11(7):36-39
13. Lei J, Li ST. Clinical research on allopurinol lowering of uric acid level of chronic renal disease patients for the delay of the progression of renal disease. Shanxi Med J (Chinese), 2009,38(9):1191-1192
14. Deng YH, Zhang P, Liu H, et al. Research on lowering serum uric acid with allopurinol to delay the progression of chronic kidney disease. J Pract Med (Chinese), 2010,26(6):982-984
15. Shen H, Liu DY. Clinical research on allopurinol in lowering serum uric acid level for the delay of the progression of chronic renal disease. China Foreign Med Treat (Chinese), 2010,13(12):88-89
16. Goicoechea M, de Vinuesa SG, Verdalles U, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol, 2010,5(8):1388-1393
17. Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev, 2006,58(1):87-114
18. Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis, 2007,50(2):239-247
19. Ruilope LM, Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertens Rep, 2001,3(3):197-202
20. Jaramillo M, Godbout M, Naccache PH, et al. Signaling events involved in macrophage chemokine expression in response to monosodium urate crystals. J Biol Chem, 2004,279(50):52 797-52 805
21. Sancher-Lozada LG, Tapia E, Santamaria J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int, 2005,67(1):237-247
22. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol, 2002,13(12):2888-2897
23. Convento MS, Pessoa E, Dalboni MA, et al. Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage. Urol Res, 2011,39(1):21-27
24. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates MCP-1 production in vascular smooth muscle cells via MAPK and COX-2. Hypertension, 2003,41(6):1287-1293
25. Roncal CA, Mu W, Croker B, et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol, 2007,292(1):F116-F122
26. Karbowska A, Boratynska M, Kusztal M, et al. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients. Transplant Proc, 2009,41(8):3052-3055
27. Sánchez-Lozada LG, Tapia E, Avila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol, 2002,283(5):F1105-F1110
28. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int, 2005,67(5):1739-1742
29. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol, 2002,282(6):F991-F997
30. Watanabe S, Kang DH, Feng L, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension, 2002,40(3):355-360
31. Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens, 2008,26(2):269-275